These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25596342)

  • 41. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
    Leoni V; Mariotti C; Tabrizi SJ; Valenza M; Wild EJ; Henley SM; Hobbs NZ; Mandelli ML; Grisoli M; Björkhem I; Cattaneo E; Di Donato S
    Brain; 2008 Nov; 131(Pt 11):2851-9. PubMed ID: 18772220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered cholesterol and fatty acid metabolism in Huntington disease.
    Block RC; Dorsey ER; Beck CA; Brenna JT; Shoulson I
    J Clin Lipidol; 2010; 4(1):17-23. PubMed ID: 20802793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Huntington disease: a single-gene degenerative disorder of the striatum.
    Nopoulos PC
    Dialogues Clin Neurosci; 2016 Mar; 18(1):91-8. PubMed ID: 27069383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease.
    Keum JW; Shin A; Gillis T; Mysore JS; Abu Elneel K; Lucente D; Hadzi T; Holmans P; Jones L; Orth M; Kwak S; MacDonald ME; Gusella JF; Lee JM
    Am J Hum Genet; 2016 Feb; 98(2):287-98. PubMed ID: 26849111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease.
    Valenza M; Leoni V; Tarditi A; Mariotti C; Björkhem I; Di Donato S; Cattaneo E
    Neurobiol Dis; 2007 Oct; 28(1):133-42. PubMed ID: 17702587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.
    Valenza M; Rigamonti D; Goffredo D; Zuccato C; Fenu S; Jamot L; Strand A; Tarditi A; Woodman B; Racchi M; Mariotti C; Di Donato S; Corsini A; Bates G; Pruss R; Olson JM; Sipione S; Tartari M; Cattaneo E
    J Neurosci; 2005 Oct; 25(43):9932-9. PubMed ID: 16251441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure?
    Morea V; Bidollari E; Colotti G; Fiorillo A; Rosati J; De Filippis L; Squitieri F; Ilari A
    Amino Acids; 2017 Jul; 49(7):1147-1157. PubMed ID: 28396959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human embryonic stem cell models of Huntington disease.
    Niclis J; Trounson AO; Dottori M; Ellisdon A; Bottomley SP; Verlinsky Y; Cram D
    Reprod Biomed Online; 2009 Jul; 19(1):106-13. PubMed ID: 19573298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cortical neurodevelopment in pre-manifest Huntington's disease.
    Kubera KM; Schmitgen MM; Hirjak D; Wolf RC; Orth M
    Neuroimage Clin; 2019; 23():101913. PubMed ID: 31491822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis.
    Culver BP; Savas JN; Park SK; Choi JH; Zheng S; Zeitlin SO; Yates JR; Tanese N
    J Biol Chem; 2012 Jun; 287(26):21599-614. PubMed ID: 22556411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease.
    Quintanilla RA; Tapia C; Pérez MJ
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1078-1083. PubMed ID: 27638306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.
    Tippett LJ; Waldvogel HJ; Snell RG; Vonsattel JP; Young AB; Faull RLM
    Adv Neurobiol; 2017; 15():129-161. PubMed ID: 28674980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients.
    Stine OC; Li SH; Pleasant N; Wagster MV; Hedreen JC; Ross CA
    Hum Mol Genet; 1995 Jan; 4(1):15-8. PubMed ID: 7711729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease.
    Valenza M; Marullo M; Di Paolo E; Cesana E; Zuccato C; Biella G; Cattaneo E
    Cell Death Differ; 2015 Apr; 22(4):690-702. PubMed ID: 25301063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease: A cross-validation study in Q175 knock-in mice.
    Shankaran M; Di Paolo E; Leoni V; Caccia C; Ferrari Bardile C; Mohammed H; Di Donato S; Kwak S; Marchionini D; Turner S; Cattaneo E; Valenza M
    Neurobiol Dis; 2017 Feb; 98():66-76. PubMed ID: 27913290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Diagnostic Use of the Plasma Quantification of 24S-Hydroxycholesterol and Other Oxysterols in Neurodegenerative Disease.
    Tripodi D; Vitarelli F; Spiti S; Leoni V
    Adv Exp Med Biol; 2024; 1440():337-351. PubMed ID: 38036888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Energy defects in Huntington's disease: Why "in vivo" evidence matters.
    Liot G; Valette J; Pépin J; Flament J; Brouillet E
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1084-1095. PubMed ID: 27639641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.
    Tourette C; Li B; Bell R; O'Hare S; Kaltenbach LS; Mooney SD; Hughes RE
    J Biol Chem; 2014 Mar; 289(10):6709-6726. PubMed ID: 24407293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutant huntingtin interacts with the sterol regulatory element-binding proteins and impairs their nuclear import.
    Di Pardo A; Monyror J; Morales LC; Kadam V; Lingrell S; Maglione V; Wozniak RW; Sipione S
    Hum Mol Genet; 2020 Feb; 29(3):418-431. PubMed ID: 31875875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue-dependent regulation of RNAP II dynamics: the missing link between transcription and trinucleotide repeat instability in diseases?
    Goula AV; Festenstein R; Merienne K
    Transcription; 2013; 4(4):172-6. PubMed ID: 23989661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.